Sectoral Asset Management’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-183,000
| Closed | -$1.85M | – | 123 |
|
|
2022
Q4 | $1.85M | Hold |
183,000
| – | – | 0.36% | 81 |
|
|
2022
Q3 | $4.1M | Hold |
183,000
| – | – | 0.81% | 56 |
|
|
2022
Q2 | $4.54M | Sell |
183,000
-10,160
| -5% | -$252K | 0.91% | 47 |
|
|
2022
Q1 | $7.49M | Hold |
193,160
| – | – | 1.33% | 30 |
|
|
2021
Q4 | $11.3M | Hold |
193,160
| – | – | 1.7% | 19 |
|
|
2021
Q3 | $11.4M | Buy |
193,160
+46,160
| +31% | +$2.74M | 0.95% | 38 |
|
|
2021
Q2 | $12.8M | Buy |
147,000
+4,500
| +3% | +$391K | 1.03% | 39 |
|
|
2021
Q1 | $11.7M | Buy |
142,500
+43,500
| +44% | +$3.59M | 0.89% | 46 |
|
|
2020
Q4 | $9M | Buy |
+99,000
| New | +$9M | 0.63% | 55 |
|